| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
188,370,000 |
| Market
Cap: |
16.70(B) |
| Last
Volume: |
1,778,607 |
Avg
Vol: |
1,398,026 |
| 52
Week Range: |
$76.22 - $99 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 811 |
| Guru Rank Value : 0.9 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
3,625 |
| Total Buy Value |
$0 |
$0 |
$0 |
$314,469 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
116,079 |
189,843 |
233,203 |
571,547 |
| Total Sell Value |
$10,217,149 |
$17,085,208 |
$20,986,230 |
$54,848,304 |
| Total People Sold |
5 |
5 |
6 |
7 |
| Total Sell Transactions |
11 |
17 |
23 |
53 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Cooper Jeffrey H |
SVP, Chief Financial Officer |
• – – |
2011-07-14 |
4 |
OE |
$17.54 |
$322,350 |
D/D |
18,378 |
58,254 |
|
- |
|
| Fuchs Henry J |
EVP, Chief Medical Officer |
• – – |
2011-07-14 |
4 |
AS |
$30.00 |
$150,000 |
D/D |
(5,000) |
36,455 |
|
- |
|
| Fuchs Henry J |
EVP, Chief Medical Officer |
• – – |
2011-07-14 |
4 |
OE |
$11.05 |
$55,250 |
D/D |
5,000 |
41,455 |
|
- |
|
| Wood Mark |
VP, Human Resources |
• – – |
2011-07-14 |
4 |
AS |
$30.00 |
$324,990 |
D/D |
(10,833) |
20,634 |
|
- |
|
| Wood Mark |
VP, Human Resources |
• – – |
2011-07-14 |
4 |
OE |
$21.51 |
$233,018 |
D/D |
10,833 |
31,467 |
|
- |
|
| Cooper Jeffrey H |
SVP, Chief Financial Officer |
• – – |
2011-07-01 |
4 |
AS |
$27.50 |
$68,750 |
D/D |
(2,500) |
39,876 |
|
- |
|
| Cooper Jeffrey H |
SVP, Chief Financial Officer |
• – – |
2011-07-01 |
4 |
OE |
$14.39 |
$35,975 |
D/D |
2,500 |
42,376 |
|
- |
|
| Fuchs Henry J |
EVP, Chief Medical Officer |
• – – |
2011-07-01 |
4 |
AS |
$27.68 |
$69,200 |
D/D |
(2,500) |
36,455 |
|
- |
|
| Fuchs Henry J |
EVP, Chief Medical Officer |
• – – |
2011-07-01 |
4 |
OE |
$11.05 |
$27,625 |
D/D |
2,500 |
38,955 |
|
- |
|
| Wood Mark |
VP, Human Resources |
• – – |
2011-06-23 |
4 |
AS |
$25.56 |
$9,481 |
D/D |
(371) |
20,634 |
|
- |
|
| Wood Mark |
VP, Human Resources |
• – – |
2011-06-22 |
4 |
AS |
$25.93 |
$42,647 |
D/D |
(1,645) |
21,005 |
|
- |
|
| Wood Mark |
VP, Human Resources |
• – – |
2011-06-22 |
4 |
OE |
$0.00 |
$25,797 |
D/D |
2,645 |
22,650 |
|
- |
|
| Baffi Robert |
EVP, Technical Operations |
• – – |
2011-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,000 |
83,160 |
|
- |
|
| Davis George Eric |
SVP, General Counsel |
• – – |
2011-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,500 |
39,651 |
|
- |
|
| Cooper Jeffrey H |
SVP, Chief Financial Officer |
• – – |
2011-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,000 |
39,876 |
|
- |
|
| Aselage Steve |
EVP, Chief Business Officer |
• – – |
2011-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
46,478 |
|
- |
|
| Wood Mark |
VP, Human Resources |
• – – |
2011-06-07 |
4 |
AS |
$27.46 |
$12,520 |
D/D |
(456) |
20,005 |
|
- |
|
| Bienaime Jean Jacques |
Chief Executive Officer |
• • – |
2011-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
132,093 |
|
- |
|
| Wood Mark |
VP, Human Resources |
• – – |
2011-06-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
20,461 |
|
- |
|
| Bienaime Jean Jacques |
Chief Executive Officer |
• • – |
2011-06-06 |
4 |
S |
$27.39 |
$54,772 |
D/D |
(2,000) |
127,093 |
|
- |
|
| Davis George Eric |
SVP, General Counsel |
• – – |
2011-05-31 |
4 |
AS |
$28.50 |
$108,300 |
D/D |
(3,800) |
38,151 |
|
- |
|
| Davis George Eric |
SVP, General Counsel |
• – – |
2011-05-31 |
4 |
OE |
$11.74 |
$44,612 |
D/D |
3,800 |
41,951 |
|
- |
|
| Bienaime Jean Jacques |
Chief Executive Officer |
• • – |
2011-05-31 |
4 |
AS |
$28.00 |
$19,880 |
D/D |
(710) |
129,093 |
|
- |
|
| Mueller Brian |
VP, Corporate Controller |
• – – |
2011-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
3,160 |
7,336 |
|
- |
|
| Bienaime Jean Jacques |
Chief Executive Officer |
• • – |
2011-05-27 |
4 |
S |
$28.00 |
$8,120 |
D/D |
(290) |
129,803 |
|
- |
|
1303 Records found
|
|
Page 26 of 53 |
|
|
1.44 (1.6%) 
